Filter by tags: United States South Africa Netherlands Clear all tag filters
8 news articles found
EU supply agency also warns of continued dependence on Moscow for VVER nuclear fuel
- Source: Nucnet
- Date: Friday, 20 October 2023
- Original article: nucnet.org/news/97-of-europe-s-natural-uranium-comes-from-overseas-but-russia-deliveries-fall-10-4-2023
Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.
Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.
According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.
- Source: Nucnet
- Date: Friday, 14 April 2023
- Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023
The International Atomic Energy Agenry (IAEA) has announced the release of the 2022 edition of Country Nuclear Power Profiles (CNPP), marking more than two decades since the initial launch of the Agency’s comprehensive guide on the status and development of national nuclear power programmes worldwide.
- Source: NEI Magazine
- Date: Saturday, 22 October 2022
- Original article: neimagazine.com/news/newsiaea-releases-annual-report-on-country-nuclear-power-profiles-10106867
The World Nuclear Association (WNA) on 8 September launched the 2021 edition of The Nuclear Fuel Report, concluding that the positive trend in nuclear generating capacity projections that began in the previous (2019) report continues.
- Source: NEI Magazine
- Date: Friday, 10 September 2021
- Original article: neimagazine.com/news/newswna-nuclear-fuel-report-urges-uranium-development-9067794
International air transport has been the main bottleneck in getting radioisotopes and nuclear medicines where they are needed during the COVID-19 pandemic, but Nuclear Medicine Europe (NMEu) says there are signs the situation is improving.
- Source: World Nuclear News
- Date: Wednesday, 29 April 2020
- Original article: world-nuclear-news.org/Articles/Air-transport-bottleneck-easing-for-medical-radioi
An agency survey conducted among operators of research reactors that produce radioisotopes for radiopharmaceuticals shows that most major actors continue to produce radioisotopes because the production facilities have been defined as essential by the relevant governments.
However, many airlines are no longer operating because of the pandemic and borders are closed, which affects the distribution of medical radioisotopes around the world.
Joao Osso Junior, head of the radioisotope products and radiation technology section at the IAEA, said the agency is working to assess the need for medical radioisotopes because most research and education activities using isotopes have been put on hold and many hospitals have delayed diagnosis applications.
- Source: Nucnet
- Date: Wednesday, 22 April 2020
- Original article: nucnet.org/news/radioisotope-industry-facing-distribution-challenges-says-iaea-4-2-2020
The production of medical radioisotopes has continued during the COVID-19 pandemic but bottlenecks in transport and distribution could lead to shortages at hospitals, according to an International Atomic Energy Agency (IAEA) survey of the research reactors where the isotopes are produced.
- Source: World Nuclear News
- Date: Wednesday, 22 April 2020
- Original article: world-nuclear-news.org/Articles/Medical-isotope-supply-chain-faces-challenges-from
Russian state nuclear corporation Rosatom in 2016 will contribute RUB24.6m ($300,000) from its state budget allocation to the International Atomic Energy Agency's (IAEA's) International Project on Innovative Nuclear Reactors and Fuel Cycles (INPRO project), according to a Russian government directive published on the official legal information portal. The directive says Rosatom and the Russian Foreign Ministry will monitor the use of the Russian contribution.
- Source: NEI Magazine
- Date: Thursday, 28 January 2016
- Original article: neimagazine.com/news/newsrussia-contributes-to-iaea-inpro-project-4795612